Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Medpage Today on MSN6d
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression RiskAmong 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
As researchers and governments consider the therapeutic uses of psychedelics, Scott Marshall stands ready to supply them.
News Medical on MSN5d
FDA-approved technology offers personalized treatment for Parkinson’s symptomsStarting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
The FDA approved the sale of Zyn nicotine pouches, which are increasingly popular with teens. But nicotine pouches cause ...
A Placer County man is sharing his personal story of recovery from severe suicidal depression. David Bartley found relief in ...
Forge consensus on a modern regulatory framework. The Trump administration could encourage the development of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback